Increased Risk of Multiple Sclerosis in the Presence of a Genetic Variant in 19-Nucleotide Downstream of miR-148a Coding Gene in Isfahan City Population in Iran

Document Type : Original Article (s)

Authors

1 MSc Student, Department of Biology, School of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran

2 Assistance Professor, Department of Biology, School of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran

Abstract

Background: Multiple sclerosis (MS) is a common disease of the central nervous system, and the incidence of this disease in women is twice that of men. Considering the importance of miRNA polymorphisms in the expression and function of mRNAs as well as the risk of disease, this study investigated the association of rs6977848 polymorphism (a genetic variant in 19-nucleotide downstream of miR-148a coding gene) with the risk of MS disease in Isfahan City population in Iran, for the first time.Methods: In this case-control study, a population of 95 healthy individuals and 99 patients were assayed. The genotype of the individuals for the polymorphism was determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). To confirm the results, a number of samples were sequenced. Then, the frequency of genotypes and alleles were evaluated.Findings: Considering the total dominance of T allele, the total TT and TG genotypes significantly increased the susceptibility to MS disease compared with the GG reference genotype [odds ratio (OR) = 2.27, P = 0.043); while considering the genotype GG as reference genotype, there was a significant difference between the TG and the reference genotypes in this population with a risk of disease (P < 0.050). However, no significant difference was observed between genotype TT and GG genotype as reference genotype.Conclusion: Findings indicate that rs6977848 polymorphism in miR-148a coding gene downstream may be effective in influencing the performance of this miRNA as well as its expression level. Moreover, the incidence of the ability of individuals to affect this disease is not significantly related to the incidence of disease in the studied populations.

Keywords

References

  1. Kacperska MJ, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A. Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study. J Mol Neurosci 2015; 56(1): 154-63.
  2. Guan H, Singh UP, Rao R, Mrelashvili D, Sen S, Hao H, et al. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells. Immunology 2016; 147(4): 488-98.
  3. Goldenberg MM. Multiple sclerosis review. P T 2012; 37(3): 175-84.
  4. Milo R, Kahana E. Multiple sclerosis: Geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9(5): A387-A394.
  5. World Health Organization. Atlas: Multiple sclerosis resources in the world 2008. Geneva, Switzerland: WHO; 2008.
  6. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008; 9(7): 516-26.
  7. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995; 37(4): 424-35.
  8. Navikas V, Link H. Review: Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996; 45(4): 322-33.
  9. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995; 182(6): 1985-96.
  10. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294(5543): 862-4.
  11. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294(5543): 853-8.
  12. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009; 4(7): e6309.
  13. Li Y, Deng X, Zeng X, Peng X. The role of Mir-148a in Cancer. J Cancer 2016; 7(10): 1233-41.
  14. Junker A. Pathophysiology of translational regulation by microRNAs in multiple sclerosis. FEBS Lett 2011; 585(23): 3738-46.
  15. Gonzalez-Martin A, Adams BD, Lai M, Shepherd J, Salvador-Bernaldez M, Salvador JM, et al. The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nat Immunol 2016; 17(4): 433-40.
  16. Qu Z, Li W, Fu B. MicroRNAs in autoimmune diseases. Biomed Res Int 2014; 2014: 527895.
  17. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010; 184(12): 6773-81.
  18. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009; 4(7): e6309.
  19. Shi H, Chen X, Jiang H, Wang X, Yu H, Sun P, et al. miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1. Oncol Lett 2018; 15(4): 4944-50.
  20. Nguyen-Dien GT, Smith RA, Haupt LM, Griffiths LR, Nguyen HT. Genetic polymorphisms in miRNAs targeting the estrogen receptor and their effect on breast cancer risk. Meta Gene 2014; 2: 226-36.
  21. Chen C, Zhou Y, Wang J, Yan Y, Peng L, Qiu W. Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation. Front Immunol 2018; 9: 1256.
Journal of Isfahan Medical School
Volume 37, Issue 541 - Serial Number 541
July and August 2019
Pages 1040-1046

Files

History

  • Receive Date: 05 August 2019
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics